Differences in hepatitis C virus core protein processing among genotypes 1 and 2

被引:2
作者
Kato, T
Miyamoto, M
Date, T
Furusaka, A
Hiramoto, J
Nagayama, K
Tsai, N
Mizokami, M
Wakita, T
机构
[1] Tokyo Metropolitan Inst Neurosci, Dept Microbiol, Fuchu, Tokyo 1838526, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Clin Mol Informat Med, Nagoya, Aichi 4678601, Japan
[3] Tokyo Med Univ, Dept Internal Med 4, Tokyo 1600023, Japan
[4] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 2018601, Japan
[5] Univ Hawaii, John A Burns Sch Med, Div Gastroenterol, Honolulu, HI 96822 USA
关键词
HCV; chronic hepatitis;
D O I
10.1016/j.hepres.2004.10.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Two forms of hepatitis C virus (HCV) core protein, p23 and p21, are produced from a precursor polyprotein. Production of p21 by cleavage at the c-terminus of p23 is considered essential for viral assembly and replication. In the present experiment, an in vitro translation and transcription assays were used to examine cleavage of p21 from p23 among 19 clones isolated from patients with chronic hepatitis, including 10 infected with genotype 1, and nine infected with genotype 2. Significantly greater p21 to p23 ratios were observed among genotype 1 clones, compared to genotype 2 clones. A comparison of the amino acid sequences of these clones revealed greater production of p21 core protein among clones which contained alanine, rather than valine, at amino acid residue 189. An exploration of Hepatitis Virus Database revealed that efficient p21 production related alanine at amino acid position 189 was observed in most clones of genotype 1 and in rare clones of genotype 2. These data suggest that the efficiency of core protein production differs among genotypes depending on differences in the c-terminus amino acid sequences of their core region. This may explain differences in some of the clinical characteristics of various genotypes or clones. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:204 / 209
页数:6
相关论文
共 33 条
  • [1] ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME
    CHOO, QL
    KUO, G
    WEINER, AJ
    OVERBY, LR
    BRADLEY, DW
    HOUGHTON, M
    [J]. SCIENCE, 1989, 244 (4902) : 359 - 362
  • [2] GENETIC ORGANIZATION AND DIVERSITY OF THE HEPATITIS-C VIRUS
    CHOO, QL
    RICHMAN, KH
    HAN, JH
    BERGER, K
    LEE, C
    DONG, C
    GALLEGOS, C
    COIT, D
    MEDINASELBY, A
    BARR, PJ
    WEINER, AJ
    BRADLEY, DW
    KUO, G
    HOUGHTON, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) : 2451 - 2455
  • [3] EXPRESSION AND IDENTIFICATION OF HEPATITIS C VIRUS POLYPROTEIN CLEAVAGE PRODUCTS
    GRAKOUI, A
    WYCHOWSKI, C
    LIN, C
    FEINSTONE, SM
    RICE, CM
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (03) : 1385 - 1395
  • [4] Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells
    Honda, M
    Kaneko, S
    Shimazaki, T
    Matsushita, E
    Kobayashi, K
    Ping, LH
    Zhang, HC
    Lemon, SM
    [J]. HEPATOLOGY, 2000, 31 (06) : 1351 - 1359
  • [5] Course and outcome of hepatitis C
    Hoofnagle, JH
    [J]. HEPATOLOGY, 2002, 36 (05) : S21 - S29
  • [6] Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer
    Kato, N
    Yoshida, H
    Ono-Nita, SK
    Kato, J
    Goto, T
    Otsuka, M
    Lan, KH
    Matsushima, K
    Shiratori, Y
    Omata, M
    [J]. HEPATOLOGY, 2000, 32 (02) : 405 - 412
  • [7] MOLECULAR-CLONING OF THE HUMAN HEPATITIS-C VIRUS GENOME FROM JAPANESE PATIENTS WITH NON-A, NON-B HEPATITIS
    KATO, N
    HIJIKATA, M
    OOTSUYAMA, Y
    NAKAGAWA, M
    OHKOSHI, S
    SUGIMURA, T
    SHIMOTOHNO, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) : 9524 - 9528
  • [8] Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice
    Kato, T
    Miyamoto, M
    Date, T
    Yasui, K
    Taya, C
    Yonekawa, H
    Ohue, C
    Yagi, S
    Seki, E
    Hirano, T
    Fujimoto, J
    Shirai, T
    Wakita, T
    [J]. CANCER SCIENCE, 2003, 94 (08) : 679 - 685
  • [9] Processing of hepatitis C virus core protein is regulated by its C-terminal sequence
    Kato, T
    Miyamoto, M
    Furusaka, A
    Date, T
    Yasui, K
    Kato, J
    Matsushima, S
    Komatsu, T
    Wakita, T
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (03) : 357 - 366
  • [10] Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient
    Kato, T
    Furusaka, A
    Miyamoto, M
    Date, T
    Yasui, K
    Hiramoto, J
    Nagayama, K
    Tanaka, T
    Wakita, T
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2001, 64 (03) : 334 - 339